MEDTR vs ORMA Comparison
Price, market cap, valuation, profitability and leverage metrics of MEDTR and ORMA side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | MEDTR | ORMA | Sector median |
|---|---|---|---|
| Last price (TL) | 18.62 | 148.00 | 18.72 |
| Daily change | −4.02% | 0.00% | −4.65% |
| Market cap | TRY 2.2B | TRY 4B | TRY 4.4B |
| P/E | 66.43 | 174.23 | 18.20 |
| P/B | 0.69 | 0.50 | 1.14 |
| Dividend yield | 0.44% | — | 0.90% |
| Return on equity | 1.14% | 0.28% | 1.78% |
| Free float | 20.21% | 13.36% | 37.21% |
Popular comparisons
Related pages
About the MEDTR vs ORMA comparison
Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and ORMA (Orma Orman Mahsulleri) side by side as of Sep 28, 2026, 11:54. Of the 14 metrics compared, MEDTR leads in 10 and ORMA leads in 4.
Highlights: Daily change: ORMA leads (0.00% vs −4.02%). Market cap: ORMA leads (TRY 4B vs TRY 2.2B). P/E: MEDTR leads (66.43 vs 174.23). P/B: ORMA leads (0.50 vs 0.69). EV/EBITDA: MEDTR leads (7.60 vs 14.48). EV/Sales: MEDTR leads (1.36 vs 2.75). Gross margin: MEDTR leads (33.71% vs 17.54%). EBITDA margin (annual): ORMA leads (12.02% vs 3.58%).
Frequently asked questions
Is MEDTR or ORMA cheaper?
By P/E, MEDTR is cheaper (66.43 vs 174.23); by P/B, ORMA trades at the lower multiple (0.69 vs 0.50).
Which is more profitable, MEDTR or ORMA?
Annual net margin is 1.35% for MEDTR and 0.52% for ORMA; return on equity is 1.14% for MEDTR and 0.28% for ORMA.
Which is more leveraged, MEDTR or ORMA?
The leverage ratio is 15.79 for MEDTR and 38.01 for ORMA; net debt/EBITDA is — for MEDTR and 5.92 for ORMA. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.